Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
KOfactor is a dietary supplement developed by KoDiscovery, formulated as a proprietary synergistic blend of three natural phytochemicals: luteolin, rutin, and epigallocatechin gallate (EGCG). The product is designed based on research suggesting that these specific polyphenols, when combined in a precise ratio, exhibit enhanced anti-proliferative and pro-apoptotic activity against cancer cells compared to the individual components. In vitro studies have demonstrated the combination's ability to induce apoptosis and inhibit the growth of various cancer cell lines. While marketed as a nutraceutical rather than a pharmaceutical drug, KoDiscovery includes KOfactor in its development pipeline for potential applications in oncological support and cancer cell killing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on KOfactor.